Viewing nowTelmisartan 40mg Tablets (Telmisartan)
Telmisartan 40mg
Tablet · Prescription medication
Daehwa Pharmaceutical Co., Ltd.

MFDS item code 201902568 · Approved 2019.04.24 · Insurance code 645605030
Treatment of essential hypertension; prevention of cardiovascular diseases (myocardial infarction, stroke, etc.)
This medication is used for patients with essential hypertension. Additionally, it helps to reduce the risk of death due to myocardial infarction, stroke, and cardiovascular disease in patients aged over 55 years who cannot tolerate ACE inhibitors and have a history of coronary artery disease, peripheral artery disease, stroke, transient ischemic attack, or are at high risk for diabetes. Therefore, this drug is effective in controlling hypertension while significantly reducing the risk of cardiovascular events.
1. Essential hypertension Adults: Telmisartan 40 mg should be administered orally once daily with water and may be taken with or without food. A dose of 20 mg once daily may be effective in some patients. If necessary, the dose may be increased to 80 mg once daily. When the dose is increased, the maximum blood pressure-lowering effect is achieved 4 ∼ 8 weeks after starting treatment. This medicine produces an additional blood pressure-lowering effect when coadministered with thiazide diuretics such as hydrochlorothiazide. 2. Reduction of cardiovascular risk Adults: It is recommended that this medicine be administered orally at a dose of 80 mg once daily with water; it may be taken with or without food. The risk-reducing effect on cardiovascular morbidity and mortality at doses below 80 mg has not been established. When starting treatment with this medicine to reduce cardiovascular risk, blood pressure monitoring is recommended, and appropriate adjustment of antihypertensive therapy may be required. ○ Patients with hepatic impairment Administer with caution to patients with mild ∼ moderate hepatic impairment, and do not exceed 40 mg once daily.
This medication can cause serious harm to the fetus if taken during pregnancy; therefore, it must be discontinued immediately if pregnancy is confirmed. Patients who have an allergic reaction to this drug, pregnant women, patients with severe liver dysfunction or biliary excretion disorders, patients with hereditary angioedema, and patients with severe renal impairment should not take this medication. Elderly patients, patients with high serum potassium levels, mild to moderate liver dysfunction, patients with cardiac valve disease, and patients with ischemic heart disease should use this drug cautiously. Since this medication lowers blood pressure, symptoms such as hypotension, dizziness, or fainting may occur; therefore, careful monitoring of symptoms is necessary during use. Serum potassium levels may increase, so serum potassium concentrations should be checked regularly, and if symptoms of hyperkalemia occur, medical attention should be sought immediately. Patients with reduced kidney function should undergo frequent kidney function tests before and after taking this medication, and if abnormal signs appear, the medication may need to be discontinued. Care should be taken when using this drug in combination with other antihypertensives as it may enhance blood pressure-lowering effects. Interactions may occur when taken with certain medications; therefore, it is essential to consult a doctor or pharmacist if taking other medications. Caution is warranted when driving or operating machinery due to the risk of dizziness and fainting. This medication contains sorbitol, so patients with fructose intolerance should avoid it. Pregnant or breastfeeding women should not take this medication, and if it must be taken, breastfeeding should be discontinued. Overdose may result in hypotension, dizziness, acute renal failure, and prompt medical treatment is necessary. Children and adolescents under 18 years of age are not recommended to use this medication as safety and efficacy have not been established. This medication should be stored in a tightly closed container away from moisture and light, and it is preferable not to transfer it to another container.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to protect it from air and moisture. It is important to maintain a storage temperature between 1 and 30 degrees Celsius at room temperature. This helps to preserve the medication's efficacy and prevent deterioration.
White or nearly white, biconvex, round tablets
10 tablets/blister X 3
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowTelmisartan 40mg
Tablet · Prescription medication
Daehwa Pharmaceutical Co., Ltd.

Telmisartan 40mg
Tablet · Prescription medication
Boehringer Ingelheim Korea Co., Ltd.

Telmisartan 80mg
Tablet · Prescription medication
Boehringer Ingelheim Korea Co., Ltd.

Telmisartan 40mg
Tablet · Prescription medication
Kwangdong Pharmaceutical Co., Ltd.

Telmisartan 80mg
Tablet · Prescription medication
Kwangdong Pharmaceutical Co., Ltd.

Telmisartan 40mg
Tablet · Prescription medication
Sam-il Pharmaceutical Co., Ltd.

Telmisartan 80mg
Tablet · Prescription medication
Samil Pharmaceutical Co., Ltd.

Telmisartan 80mg
Tablet · Prescription medication
Genewon Science Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.